- Home
- EXEL vs ASTS Comparison
EXEL vs ASTS Comparison
Compare EXEL & ASTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ASTS
- Stock Information
- Founded
- EXEL 1994
- ASTS 2019
- Country
- EXEL United States
- ASTS United States
- Employees
- EXEL 1147
- ASTS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ASTS Telecommunications Equipment
- Sector
- EXEL Health Care
- ASTS Consumer Discretionary
- Exchange
- EXEL Nasdaq
- ASTS Nasdaq
- Market Cap
- EXEL 10.4B
- ASTS 13.6B
- IPO Year
- EXEL 2000
- ASTS N/A
- Fundamental
- Price
- EXEL $38.31
- ASTS $48.08
- Analyst Decision
- EXEL Buy
- ASTS Buy
- Analyst Count
- EXEL 21
- ASTS 7
- Target Price
- EXEL $43.65
- ASTS $49.48
- AVG Volume (30 Days)
- EXEL 4.0M
- ASTS 10.4M
- Earning Date
- EXEL 07-28-2025
- ASTS 08-11-2025
- Dividend Yield
- EXEL N/A
- ASTS N/A
- EPS Growth
- EXEL 81.76
- ASTS N/A
- EPS
- EXEL 2.08
- ASTS N/A
- Revenue
- EXEL $2,230,005,000.00
- ASTS $4,892,000.00
- Revenue This Year
- EXEL $9.88
- ASTS $1,331.30
- Revenue Next Year
- EXEL $12.59
- ASTS $370.72
- P/E Ratio
- EXEL $18.45
- ASTS N/A
- Revenue Growth
- EXEL 10.73
- ASTS 249.43
- 52 Week Low
- EXEL $25.12
- ASTS $17.50
- 52 Week High
- EXEL $49.62
- ASTS $60.95
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- ASTS 45.97
- Support Level
- EXEL $37.01
- ASTS $47.12
- Resistance Level
- EXEL $38.78
- ASTS $51.95
- Average True Range (ATR)
- EXEL 1.12
- ASTS 3.38
- MACD
- EXEL 0.07
- ASTS -0.97
- Stochastic Oscillator
- EXEL 83.79
- ASTS 25.39
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.